References
- Lipton RB, Goadsby PJ, Sawyer JPC, et al. Migraine: diagnosis and assessment of disability. Rev Contemp Pharmacother 2000;11:63–73
- Giffin NJ, Kowacs F, Libri V, et al. Effect of the adenosine (A1) receptor agonist GR79236 on trigeminal nociception with blink reflex recordings in healthy human subjects. Cephalalgia 2001;21:269
- Graham JR, Suby HI, LeCompte PR, Sadowsky NL. Fibrotic disorders associated with methysergide therapy for headache. N Engl J Med 1966;274:360–8
- Saper JR, Silberstein SD, Lake AE, Winters ME. Double-blind trial of fluoxetine: chronic daily headache and migraine. Headache 1994;34:497–502
- Goadsby PJ, Lipton RB, Ferrari MD. Migraine: current understanding and management. N Engl J Med 2001:in press
- Menken M, Munsat TL, Toole JF. The global burden of disease study – implications for neurology. Arch Neurol 2000; 57:418–20
- Welch KMA, Mathew NT, Stone P, et al. Tolerability of sumatriptan: clinical trials and post-marketing experience. Cephalalgia 2000;20: 687–94
- Pilgrim AJ. Methodology of clinical trials of sumatriptan in migraine and cluster headache. Eur Neurol 1991;31:295–9
- Davies GM, Santanello NC, Lipton RB. Determinants of patient satisfaction with migraine therapy. Cephalalgia 2000;20:554–60